Date: September 25 - 28, 2017
Location: St Julien Hotel and Spa
The Boulder Peptide Symposium seeks to bring together key decision leaders from both industry and academia to discuss the future of peptide therapeutics. Peptide therapeutics are potent and highly selective yet their development into effective treatments can be challenged by limited delivery routes, product stability, manufacturing challenges and an evolving regulatory landscape. BPS is the key forum where these challenges will be identified, discussed, and one day—addressed.
Session: Drug Delivery Session
Date: Wednesday, September 27
Time: 10:40am - 11:10am
Presentation Title: Transitioning peptides from Discovery to the Clinic
Speaker: Lisa Caralli, Sr. Director, Catalent Pharma Solutions